Beck Automation Expands Into the Medical Market

Beck Automation (Swiss based) develops innovative automation solutions that can be integrated into the production processes of plastics processing industries. The company, which is now in its third generation of family management, has now established another mainstay in the medical sector. The focus is on producers of medical consumables that are manufactured using injection moulding. The first projects have already been realized.

“We have been looking at this option for about four years, as Switzerland is a global medical location with pharmaceutical companies and research and development facilities. Furthermore, we see an increasing demand for automation solutions, which we can serve with our profound automation know-how and our many years of experience regarding the development and production of customized solutions. Therefore, our entry into the medical market is therefore a consistent step. At the same time, it represents a milestone in the history of Beck Automation”, explains Nicolas Beck, managing owner of Beck Automation AG, the step into the medical sector. A separate business unit was founded within the company for this purpose. “We want to focus specifically on the medical market. For this reason, the medical business unit will operate autonomously within our organization in order to be able to react competently, flexibly, and quickly to customer requirements,” adds Nino Zehnder, Marketing and Sales Manager at Beck Automation.

Already in the planning phase of the new business unit, a start was made on building up product- and market-specific knowledge as well as personnel. Engineering, project management, and service were aligned according to the new, specific conditions.

Ralf Ziemer completes the team in sales with his profound industry know-how. “There are many automation possibilities in the medical and cosmetics industry. Beck has 36 years of experience in the field of automation. Because of this, our products are very interesting for pharmaceutical companies, their manufacturers, but also for companies in the cosmetics industry. We offer excellent solution possibilities,” says Ziemer.

Beck is aware that medical components are not standard parts. The products require very individual, customized solutions and this is where the company sees its core competence. “Our customers benefit from our highly efficient, customized systems that offer sustainable economic advantages. We set ourselves the highest standards in product and production reliability. We ensure this through solutions that are reproducible, validatable and hygienically flawless,” Zehnder continues.

Medical products must not pose any risks to patients and users, which is why they must be free of defects. “Our systems rule out mismanipulation, are modular in design, and can be realized in a small space. Cost pressure is constantly increasing, and production space, especially in cleanrooms, is expensive. We have to take this into account,” adds Ziemer.  Beck’s solutions comply with the regulations of Good Manufacturing Practice (GMP) and the U.S. Food and Drug Administration (FDA) and are suitable for cleanrooms up to class ISO 8.

 

 

Hot this week

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.

Boston Scientific Obtains CE Mark for ACURATE Prime Aortic Valve System

The ACURATE Prime aortic valve system is designed with several features to build upon the clinical performance of the ACURATE neo2™ platform including an additional valve size, which expands the treatment range to patients with a larger anatomy.

Noctrix Health Announces New CMS Reimbursement Codes and Payment for Nidra Tonic Motor Activation Therapy for Restless Legs Syndrome

Nidra TOMAC Tonic Motor Activation Therapy, which was authorized for marketing in the United States last year following its designation as a "Breakthrough Device" by the US Food & Drug Administration (FDA), remains the only clinically validated, non-pharmaceutical treatment available for patients with RLS.